International Stroke Genetics Consortium (ISGC) United States of America (USA)
Research
Date range: 1 June 2022 - 31 May 2023
Research collaboration: International Stroke Genetics Consortium (ISGC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
International Stroke Genetics Consortium (ISGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Beth Israel Deaconess Medical Center (BIDMC)
- Boston University (BU)
- Brigham and Women's Hospital (BWH)
- Broad Institute of MIT and Harvard
- Cedars-Sinai Medical Center (Cedars-Sinai)
- Celera Corporation
- Columbia University in the City of New York (CU)
- Duke University
- Emory University
- Erasmus University Rotterdam (EUR)
- Framingham Heart Study (FHS)
- Hospital del Mar Medical Research Institute (IMIM)
- IRCCS Carlo Besta Neurological Institute
- Imperial College London (ICL)
- Jagiellonian University (UJ)
- Ludwig Maximilians University of Munich (LMU)
- Lund University (LU)
- Mayo Clinic
- NIH National Institute on Aging (NIA)
- Obafemi Awolowo University (OAU)
- Sahlgrenska University Hospital (SU), GU
- St George's, University of London (SGUL)
- Taoyuan Chang Gung Memorial Hospital, Chang Gung Medical Foundation
- The University of Alabama (UA)
- The University of Edinburgh
- The University of Newcastle (UON)
- The University of Utah (Utah)
- UCL
- University Hospitals Leuven (UZ Leuven)
- University of Aberdeen
- University of Cambridge
- University of Cincinnati (UC)
- University of Helsinki
- University of Maryland, Baltimore (UMB)
- University of Miami (UM)
- University of Milan (UNIMI)
- University of Oxford
- University of Vermont (UVM)
- University of Virginia (UVA)
- University of Washington (UW)
- Vall d'Hebron University Hospital (HUVH), ICS
- Wake Forest University (WFU)
- World Hypertension League